Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Flagship Pioneering Inc.
BioCentury | Feb 7, 2025
Management Tracks
Biondi becomes managing partner at Flagship
Plus: New CMOs at Epitopea and Cadrenal
BioCentury | Jan 27, 2025
Discovery & Translation
Science Spotlight: Improving safety of live-attenuated vaccines
BioCentury’s roundup of translational innovations also includes base editing for prion disease, a Flagship collab, and six papers with links to newcos
BioCentury | Jan 14, 2025
Finance
How VCs at the AI-bio interface set up their portfolios for success
Some firms are playing an active role in overcoming data starvation and bolstering the infrastructure ecosystem
BioCentury | Jan 10, 2025
Finance
Life science VCs driving AI innovation: the view from the interface in 2025
How VC firms focused on AI-driven drug development think about the resources and strategies needed to turn promise into reality
BioCentury | Jan 4, 2025
Emerging Company Profile
Mirai: One-stop shop for genetic medicine developers
With $50M from Flagship, Mirai is optimizing nucleic acid design, delivery and manufacturing for clients
BioCentury | Oct 24, 2024
Management Tracks
Junaid Bajwa joins Flagship as senior partner, head of U.K.
Plus: Promotions at Citigroup and updates from FDA’s CDRH, LigaChem, Alphina, Kenai and Precision Medicine
BioCentury | Oct 11, 2024
Management Tracks
Flagship takes on a third managing partner
Plus: New CEOs at Wheeler, Abalos, Oncovita, Syneos and Calluna, and updates from Phase, Ziphius and more
BioCentury | Sep 14, 2024
Management Tracks
Egle names Detheux chairman
Plus: BeiGene adds to commercial leadership, hiring Pfizer veteran Matt Shaulis, and updates from Wells Fargo, Flagship, Alume, Cytek, Aetion and 180 Life Sciences
BioCentury | Sep 5, 2024
Discovery & Translation
AI for target discovery: the start of a long road
Back to School 2024: Investments in AI in drug discovery pick up, as the picture starts to form of how target discovery may benefit
BioCentury | Sep 4, 2024
Deals
Deals Report: Pfizer collaborates with second Flagship company, three China deals, and more
BioCentury’s weekly deals analysis
Items per page:
1 - 10 of 65